Literature DB >> 1641167

Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.

M Vera-Ramirez1, M Charlet, G J Parry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1641167     DOI： 10.1212/wnl.42.8.1636-a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 2.  Side-effects of intravenous immune globulins.

Authors:  C Duhem; M A Dicato; F Ries
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 3.  Adverse effects of intravenous immunoglobulin.

Authors:  S A Misbah; H M Chapel
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

4.  Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease.

Authors:  Yasushi Kemmotsu; Tomotaka Nakayama; Hiroyuki Matsuura; Tsutomu Saji
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-14       Impact factor: 3.054

Review 5.  Intravenous Immunoglobulin-Induced Aseptic Meningitis-A Narrative Review of the Diagnostic Process, Pathogenesis, Preventative Measures and Treatment.

Authors:  Anna Kretowska-Grunwald; Maryna Krawczuk-Rybak; Malgorzata Sawicka-Zukowska
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.